Australia's Imugene hits 1-1/2-month high on collaboration with RenovoRx

RenovoRx

20/07/2023 02:24

** Shares of Imugene Ltd  IMU.AX  rise as much as 4.8% to
A$0.110, their highest level since June 5
    ** Immune-oncology co announces collaboration with 
biopharmaceutical co RenovoRx Inc  RNXT.O 
    ** Says collaboration will explore trans-arterial delivery
of Imugene's CF33 oncolytic virus therapy 
    ** Says collaboration will help facilitate treatment of
difficult-to-access tumours 
    ** Shares on track for their second session of gain 
    ** Shares down 27.6% YTD, as of last close 

 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))